The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Circulating levels of IGF-1 directly regulate bone growth and density
Open accessAbstract
IGF-1 is a growth-promoting polypeptide that is essential for normal growth and development. In serum, the majority of the IGFs exist in a 150-kDa complex including the IGF molecule, IGF binding protein 3 (IGFBP-3), and the acid labile subunit (ALS). This complex prolongs the half-life of serum IGFs and facilitates their endocrine actions. Liver IGF-1-deficient (LID) mice and ALS knockout (ALSKO) mice exhibited relatively normal growth and development, despite having 75% and 65% reductions in serum IGF-1 levels, respectively. Double gene disrupted mice were generated by crossing LID+ALSKO mice. These mice exhibited further reductions in serum IGF-1 levels and a significant reduction in linear growth. The proximal growth plates of the tibiae of LID+ALSKO mice were smaller in total height as well as in the height of the proliferative and hypertrophic zones of chondrocytes. There was also a 10% decrease in bone mineral density and a greater than 35% decrease in periosteal circumference and cortical thickness in these mice. IGF-1 treatment for 4 weeks restored the total height of the proximal growth plate of the tibia. Thus, the double gene disruption LID+ALSKO mouse model demonstrates that a threshold concentration of circulating IGF-1 is necessary for normal bone growth and suggests that IGF-1, IGFBP-3, and ALS play a prominent role in the pathophysiology of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420
Self-citationHildebrand, T., Laib, A., Müller, R., Dequeker, J., & Rüegsegger, P. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1167 · Cited by 1,303
The Somatomedin Hypothesis: 2001
Le Roith, D., Bondy, C., Yakar, S., Liu, J.-L., & Butler, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0419 · Cited by 1,257
Self-citationRoles of Growth Hormone and Insulin-like Growth Factor 1 in Mouse Postnatal Growth
Lupu, F., Terwilliger, J. D., Lee, K., Segre, G. V., & Efstratiadis, A. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9975 · Cited by 771
Genetic variability in adult bone density among inbred strains of mice
Beamer, W. G., Donahue, L. R., Rosen, C. J., & Baylink, D. J. (1996) · Bone · doi:10.1016/8756-3282(96)00047-6 · Cited by 630
Self-citationDe Mellow, J. S. M., & Baxter, R. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80824-6 · Cited by 483
Lassarre, C., Hardouin, S., Daffos, F., Forestier, F., Frankenne, F., & Binoux, M. (1991) · Pediatric Research · doi:10.1203/00006450-199103000-00001 · Cited by 411
Liver-Specific igf-1 Gene Deletion Leads to Muscle Insulin Insensitivity
Yakar, S., Liu, J.-L., Fernandez, A. M., Wu, Y., Schally, A. V., Frystyk, J., Chernausek, S. D., Mejia, W., & Le Roith, D. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1110 · Cited by 343
Self-citationHOSSENLOPP, P., SEGOVIA, B., LASSARRE, C., ROGHANI, M., BREDON, M., & BINOUX, M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-797 · Cited by 340
Cited by
Muscle–Organ Crosstalk: The Emerging Roles of Myokines
Severinsen, M. C. K., & Pedersen, B. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa016 · Cited by 1,226
“Insulin-like growth factor 1 (IGF-1) has been shown to have a positive effect on bone formation (170).”
BackgroundSkeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
“There is an epidemiological and genetic correlation between bone mass and serum IGF-1, rather than between bone mass and serum growth hormon”
BackgroundEndochondral ossification: How cartilage is converted into bone in the developing skeleton
Mackie, E. J., Ahmed, Y. A., Tatarczuch, L., Chen, K.-S., & Mirams, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.009 · Cited by 1,022
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Gut microbiota induce IGF-1 and promote bone formation and growth
Yan, J., Herzog, J. W., Tsang, K., Brennan, C. A., Bower, M. A., Garrett, W. S., Sartor, B. R., Aliprantis, A. O., & Charles, J. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607235113 · Cited by 750
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Chimenti, I., Smith, R. R., Li, T.-S., Gerstenblith, G., Messina, E., Giacomello, A., & Marbán, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.210682 · Cited by 660
Systemic and Local Regulation of the Growth Plate
van der Eerden, B. C. J., Karperien, M., & Wit, J. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0033 · Cited by 558
Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement
Siddiqui, J. A., & Partridge, N. C. (2016) · Physiology · doi:10.1152/physiol.00061.2014 · Cited by 534
Osteocytes: master orchestrators of bone
Schaffler, M. B., Cheung, W.-Y., Majeska, R., & Kennedy, O. (2014) · Calcified Tissue International · doi:10.1007/s00223-013-9790-y · Cited by 514
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Self-citationThe Role of Liver-Derived Insulin-Like Growth Factor-I
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0010 · Cited by 453
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
“Transgenic depletion of blood-borne IGF-I indicates that this peripheral source of growth-factor drive also contributes to adult bone growth (283).”
BackgroundEndocrine Regulation of the Growth Plate
Nilsson, O., Marino, R., De Luca, F., Phillip, M., & Baron, J. (2005) · Hormone Research in Paediatrics · doi:10.1159/000088791 · Cited by 441
Periosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 431
Caloric restriction leads to high marrow adiposity and low bone mass in growing mice
Devlin, M. J., Cloutier, A. M., Thomas, N. A., Panus, D. A., Lotinun, S., Pinz, I., Baron, R., Rosen, C. J., & Bouxsein, M. L. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.82 · Cited by 361
Self-citationSchlapschy, M., Binder, U., Borger, C., Theobald, I., Wachinger, K., Kisling, S., Haller, D., & Skerra, A. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt023 · Cited by 342
Frystyk, J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.06.001 · Cited by 338
Self-citationEffect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
Locatelli, V., & Bianchi, V. E. (2014) · International Journal of Endocrinology · doi:10.1155/2014/235060 · Cited by 307
Dehkhoda, F., Lee, C. M. M., Medina, J., & Brooks, A. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00035 · Cited by 304
Nieto-Estévez, V., Defterali, Ç., & Vicario-Abejón, C. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00052 · Cited by 274
Fan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T., DiGirolamo, D. J., Kopchick, J. J., Le Roith, D., Trucco, M., & Sperling, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014308 · Cited by 255
Self-citationPathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people
Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199
“Patients with haploinsufficiency of IGF-1 receptor have been found to have undesirable changes to bone architecture in accordance with this hypothesis [30, 31].”
ResultThe role of growth hormone and insulin-like growth factor-I in the liver
Takahashi, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071447 · Cited by 193
Thompson, E. M., Matsiko, A., Farrell, E., Kelly, D. J., & O'Brien, F. J. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1918 · Cited by 147
“A study elegantly demonstrated that a reduction in IGF-1 levels correlated with interstitial growth of long bones in mice (Yakar et al., 2002).”
Hamrick, M. W., Ding, K.-H., Ponnala, S., Ferrari, S. L., & Isales, C. M. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080213 · Cited by 143
O’Shea, P. J., Bassett, J. H. D., Sriskantharajah, S., Ying, H., Cheng, S.-Y., & Williams, G. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0224 · Cited by 126
Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
Franklin, M., Bu, S. Y., Lerner, M. R., Lancaster, E. A., Bellmer, D., Marlow, D., Lightfoot, S. A., Arjmandi, B. H., Brackett, D. J., Lucas, E. A., et al. (2006) · Bone · doi:10.1016/j.bone.2006.05.024 · Cited by 120
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Li, L., Rao, S., Cheng, Y., Zhuo, X., Deng, C., Xu, N., Zhang, H., & Yang, L. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.810 · Cited by 109
“Exogenous IGF‐1 promoted the growth of longitudinal femoral (Yakar et al., 2002).”
BackgroundThe Insulin-Like Growth Factor System in Bone
Kawai, M., & Rosen, C. J. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.013 · Cited by 106
Self-citationGuo, B., Zhang, Z.-K., Liang, C., Li, J., Liu, J., Lu, A., Zhang, B.-T., & Zhang, G. (2017) · Calcified Tissue International · doi:10.1007/s00223-016-0209-4 · Cited by 96
Self-citationPleiotropic effects of extended blockade of CSF1R signaling in adult mice
Sauter, K. A., Pridans, C., Sehgal, A., Tsai, Y. T., Bradford, B. M., Raza, S., Moffat, L., Gow, D. J., Beard, P. M., Mabbott, N. A., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0114-006r · Cited by 100
“Bone growth and density are directly regulated by circulating levels of IGF1 [21].”
BackgroundInfluentialCurrent understanding of osteoporosis associated with liver disease
Nakchbandi, I. A., & van der Merwe, S. W. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.166 · Cited by 98
SIRT2 regulates extracellular vesicle-mediated liver-bone communication
Lin, L., Guo, Z., He, E., Long, X., Wang, D., Zhang, Y., Guo, W., Wei, Q., He, W., Wu, W., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00803-0 · Cited by 88
IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women
Liu, J.-M., Zhao, H.-Y., Ning, G., Chen, Y., Zhang, L.-Z., Sun, L.-H., Zhao, Y.-J., Xu, M.-Y., & Chen, J.-L. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0799-z · Cited by 81
“In addition to the direct anabolic infl uence of IGF-1 on the skeleton [19,26], the reciprocal effects of IGF-1, lean mass, and bone mass should not be neglected.”
BackgroundSelf-citationCLPP deficiency protects against metabolic syndrome but hinders adaptive thermogenesis
Becker, C., Kukat, A., Szczepanowska, K., Hermans, S., Senft, K., Brandscheid, C. P., Maiti, P., & Trifunovic, A. (2018) · The EMBO Reports · doi:10.15252/embr.201745126 · Cited by 60
Genomics and the Immune Landscape of Osteosarcoma
Wu, C.-C., & Livingston, J. A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43085-6_2 · Cited by 58
Pennisi, P., Gavrilova, O., Setser-Portas, J., Jou, W., Santopietro, S., Clemmons, D., Yakar, S., & LeRoith, D. (2006) · Endocrinology · doi:10.1210/en.2005-1556 · Cited by 51
Self-citationEmerging role of liver-bone axis in osteoporosis
Gao, H., Peng, X., Li, N., Gou, L., Xu, T., Wang, Y., Qin, J., Liang, H., Ma, P., Li, S., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.07.008 · Cited by 36
“Shoshana Yakar [80] reported decreased circulating IGF-1 levels and attenuated bone growth in liver Igf-1 and acid labile subunit (ALS) double-knockout mice, which indicated the important role of the IGF-1/IGFBP3/ALS ternary complex in osteoporosis pathophysiology.”
BackgroundAge-related bone loss is associated with FGF21 but not IGFBP1 in healthy adults
Lee, S. Y., Fam, K. D., Chia, K. L., Yap, M. M. C., Goh, J., Yeo, K. P., Yap, E. P. H., Chotirmall, S. H., & Lim, C. L. (2020) · Experimental Physiology · doi:10.1113/ep088351 · Cited by 24
“For example, BMD decreased by 10% in liverspecific IGF1 knockout mice, which was restored with 4 weeks of IGF1 treatment (Yakar et al., 2002).”
BackgroundFournier, C., Rizzoli, R., & Ammann, P. (2014) · Endocrinology · doi:10.1210/en.2014-1308 · Cited by 15
Microgravity, Bone Homeostasis, and Insulin-like Growth Factor-1
Smith, J. K. (2020) · doi:10.20944/preprints202005.0293.v1 · Cited by 12
Metadata
- Authors
- Yakar, S., Rosen, C. J., Beamer, W. G., Ackert-Bicknell, C. L., Wu, Y., Liu, J.-L., Ooi, G. T., Setser, J., Frystyk, J., Boisclair, Y. R., & LeRoith, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-09-15
- Volume
- 110
- Issue
- 6
- Pages
- 771-781
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2166044131
- Cited by
- 844
- References
- 33
- FWCI
- 21.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.